1 | warranted | 4,056 |
2 | lacking | 3,288 |
3 | scarce | 1,261 |
4 | justified | 1,175 |
5 | underway | 667 |
6 | unavailable | 422 |
7 | awaited | 305 |
8 | underutilized | 197 |
9 | underused | 187 |
10 | merited | 35 |
11 | infeasible | 29 |
12 | underprescribed | 13 |
13 | inexistent | 11 |
14 | under-evaluated | 10 |
15 | under-prescribed | 9 |
16 | preload-dependent | 8 |
17 | disconfirmed | 5 |
18 | cost-ineffective | 4 |
19 | nonelectrolytes | 4 |
20 | sketched | 4 |
21 | warrented | 4 |
22 | anynana | 3 |
23 | ill-founded | 3 |
24 | overweighted | 3 |
25 | positivity-driven | 3 |
26 | under-identified | 3 |
27 | consistency-driven | 2 |
28 | iba10g2 | 2 |
29 | misknown | 2 |
30 | nct00392847 | 2 |
31 | nonferroelectric | 2 |
32 | overworked | 2 |
33 | problematized | 2 |
34 | progestogen-intolerant | 2 |
35 | pxr-dependent | 2 |
36 | recommanded | 2 |
37 | sert-f604q | 2 |
38 | stress-prone | 2 |
39 | unkown | 2 |
40 | .5-1.5 | 1 |
41 | 0.010-1.8 | 1 |
42 | 0.4-40 | 1 |
43 | 10-2,000 | 1 |
44 | 143.6±4.6 | 1 |
45 | 159-279 | 1 |
46 | 2,834-3,139 | 1 |
47 | 282.025 | 1 |
48 | abietane-type | 1 |
49 | blinded.we | 1 |
50 | cyclooxygenase-2-independent | 1 |
51 | dose-depend | 1 |
52 | enol/keto | 1 |
53 | excists | 1 |
54 | increasinglyasking | 1 |
55 | inflltration | 1 |
56 | k21a/n272d | 1 |
57 | n272d | 1 |
58 | pended | 1 |
59 | performed.follow-up | 1 |
60 | poorly-tolerated | 1 |
61 | post-normalization | 1 |
62 | saying.the | 1 |
63 | self-funding | 1 |
64 | unassailable | 1 |
65 | used.analysis | 1 |
66 | y-7571 | 1 |
1 | .5-1.5 | 1 |
2 | 0.010-1.8 | 1 |
3 | 0.4-40 | 1 |
4 | 10-2,000 | 1 |
5 | 143.6±4.6 | 1 |
6 | 159-279 | 1 |
7 | 2,834-3,139 | 1 |
8 | 282.025 | 1 |
9 | abietane-type | 1 |
10 | anynana | 3 |
11 | awaited | 305 |
12 | blinded.we | 1 |
13 | consistency-driven | 2 |
14 | cost-ineffective | 4 |
15 | cyclooxygenase-2-independent | 1 |
16 | disconfirmed | 5 |
17 | dose-depend | 1 |
18 | enol/keto | 1 |
19 | excists | 1 |
20 | iba10g2 | 2 |
21 | ill-founded | 3 |
22 | increasinglyasking | 1 |
23 | inexistent | 11 |
24 | infeasible | 29 |
25 | inflltration | 1 |
26 | justified | 1,175 |
27 | k21a/n272d | 1 |
28 | lacking | 3,288 |
29 | merited | 35 |
30 | misknown | 2 |
31 | n272d | 1 |
32 | nct00392847 | 2 |
33 | nonelectrolytes | 4 |
34 | nonferroelectric | 2 |
35 | overweighted | 3 |
36 | overworked | 2 |
37 | pended | 1 |
38 | performed.follow-up | 1 |
39 | poorly-tolerated | 1 |
40 | positivity-driven | 3 |
41 | post-normalization | 1 |
42 | preload-dependent | 8 |
43 | problematized | 2 |
44 | progestogen-intolerant | 2 |
45 | pxr-dependent | 2 |
46 | recommanded | 2 |
47 | saying.the | 1 |
48 | scarce | 1,261 |
49 | self-funding | 1 |
50 | sert-f604q | 2 |
51 | sketched | 4 |
52 | stress-prone | 2 |
53 | unassailable | 1 |
54 | unavailable | 422 |
55 | under-evaluated | 10 |
56 | under-identified | 3 |
57 | under-prescribed | 9 |
58 | underprescribed | 13 |
59 | underused | 187 |
60 | underutilized | 197 |
61 | underway | 667 |
62 | unkown | 2 |
63 | used.analysis | 1 |
64 | warranted | 4,056 |
65 | warrented | 4 |
66 | y-7571 | 1 |
1 | 10-2,000 | 1 |
2 | 0.4-40 | 1 |
3 | y-7571 | 1 |
4 | iba10g2 | 2 |
5 | .5-1.5 | 1 |
6 | 282.025 | 1 |
7 | 143.6±4.6 | 1 |
8 | nct00392847 | 2 |
9 | 0.010-1.8 | 1 |
10 | 2,834-3,139 | 1 |
11 | 159-279 | 1 |
12 | anynana | 3 |
13 | nonferroelectric | 2 |
14 | n272d | 1 |
15 | k21a/n272d | 1 |
16 | under-prescribed | 9 |
17 | underprescribed | 13 |
18 | recommanded | 2 |
19 | pended | 1 |
20 | ill-founded | 3 |
21 | sketched | 4 |
22 | under-identified | 3 |
23 | justified | 1,175 |
24 | overworked | 2 |
25 | disconfirmed | 5 |
26 | underused | 187 |
27 | poorly-tolerated | 1 |
28 | under-evaluated | 10 |
29 | overweighted | 3 |
30 | awaited | 305 |
31 | merited | 35 |
32 | warranted | 4,056 |
33 | warrented | 4 |
34 | underutilized | 197 |
35 | problematized | 2 |
36 | dose-depend | 1 |
37 | scarce | 1,261 |
38 | saying.the | 1 |
39 | unassailable | 1 |
40 | unavailable | 422 |
41 | infeasible | 29 |
42 | stress-prone | 2 |
43 | abietane-type | 1 |
44 | cost-ineffective | 4 |
45 | blinded.we | 1 |
46 | self-funding | 1 |
47 | lacking | 3,288 |
48 | increasinglyasking | 1 |
49 | consistency-driven | 2 |
50 | positivity-driven | 3 |
51 | inflltration | 1 |
52 | post-normalization | 1 |
53 | unkown | 2 |
54 | misknown | 2 |
55 | enol/keto | 1 |
56 | performed.follow-up | 1 |
57 | sert-f604q | 2 |
58 | nonelectrolytes | 4 |
59 | used.analysis | 1 |
60 | excists | 1 |
61 | progestogen-intolerant | 2 |
62 | preload-dependent | 8 |
63 | pxr-dependent | 2 |
64 | cyclooxygenase-2-independent | 1 |
65 | inexistent | 11 |
66 | underway | 667 |